20-F: Oriental Rise Holdings 2025 Annual Report Analysis

Oriental Rise Holdings reports a significant decline in 2025 financial performance amid market oversupply and economic headwinds in China.

Summary

• Revenue decreased by 18.62% to $12.2 million in 2025 from $15.0 million in 2024.
• Net profit fell by 67.39% to $0.68 million in 2025 from $2.09 million in 2024.
• Gross profit margin contracted sharply to 10.8% in 2025 from 26.2% in 2024.
• The company faces a delisting threat from Nasdaq due to its share price closing below $1.00 for 30 consecutive business days.
• Management identified material weaknesses in internal controls over financial reporting, including lack of review procedures and insufficient U.S. GAAP expertise.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as highly negative due to deteriorating financial performance, material weaknesses in internal controls, and an imminent threat of delisting from Nasdaq.

Positives

• Maintained a vertically integrated business model covering cultivation, processing, and sales.
• Successfully completed a private placement in July 2025, raising approximately $6.9 million in gross proceeds.
• Recognized a $1.67 million gain on the valuation of warrants in 2025.

Negatives

• Significant decline in average selling prices for tea products due to market oversupply.
• Revenue from refined tea dropped from $1.2 million in 2024 to $6,000 in 2025.
• Administrative expenses increased by 46.32% to $2.07 million, driven by higher professional and compliance costs.
• Operating cash flow turned negative, with $583,000 used in operating activities in 2025 compared to $3.15 million generated in 2024.

Risks

• Potential delisting from Nasdaq due to failure to meet minimum bid price requirements.
• Significant reliance on top five customers, accounting for 45.04% of total revenue in 2025.
• Regulatory and operational risks associated with conducting all business operations in China.
• Uncertainty regarding the renewal of contractual management rights for tea gardens upon expiration.
• Non-compliance with certain PRC laws, including fire safety inspection procedures and social insurance/housing fund contributions.

Future Outlook

The company intends to focus on research and development, new product development, and expanding production capacity, while relying on existing cash reserves and potential future financing. Management aims to regain compliance with Nasdaq listing rules through potential further corporate actions.

Management Comments

• Management acknowledges that internal control over financial reporting was not effective as of December 31, 2025.
• Management intends to regain compliance with the Nasdaq minimum bid price rule by effecting a reverse stock split or other measures.

Industry Context

StockSavvy.ai notes that the Chinese tea industry is currently experiencing significant fragmentation and oversupply, particularly in the white tea segment, which has pressured margins for producers like Oriental Rise. The company's struggle with market saturation and regulatory compliance is consistent with broader challenges faced by small-cap, China-based issuers listed on U.S. exchanges.

Comparison to Industry Standards

• The company's gross margin of 10.8% is significantly lower than established premium tea brands, reflecting the impact of commodity-like pricing in the current oversupplied market.
• The reliance on top five customers (45%) is high compared to diversified consumer goods companies, increasing vulnerability to individual contract losses.

Corporate Governance

Related Party Transactions

• Amounts due to controlling shareholder Mr. Chun Sun Wong and shareholder Mr. Zhuo Wang totaled $1.64 million as of December 31, 2025.

Stakeholder Impact

• Shareholders face significant risk of loss due to potential delisting and declining financial performance.
• Employees may face uncertainty regarding future growth and stability of the company.

Next Steps

• Attend Nasdaq hearing on May 19, 2026, to appeal delisting.
• Implement remedial measures to address internal control deficiencies.
• Continue monitoring market conditions and potential for further capital raising.

Key Dates

Recommendation

The combination of declining revenue and margins, material weaknesses in financial reporting, and the high probability of delisting from a major exchange makes this a high-risk investment that does not meet institutional quality standards.

Keywords

Oriental Rise Holdings, ORIS, Tea Industry, China Agriculture, Nasdaq Delisting, White Tea, SEC Filing